Inovio Pharmaceuticals
INO
INO
157 hedge funds and large institutions have $327M invested in Inovio Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
47% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 30
1.52% less ownership
Funds ownership: 4.04% → 2.51% (-1.5%)
Holders
157
Holding in Top 10
1
Calls
$36M
Puts
$22.2M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$9.56M | |
| 3 | +$7.38M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.03M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.48M |
Top Sellers
| 1 | -$28.9M | |
| 2 | -$21.9M | |
| 3 | -$17.4M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$17.4M |
| 5 |
Morgan Stanley
New York
|
-$8.65M |